131 related articles for article (PubMed ID: 36306724)
41. The Tale of CHD4 in DNA Damage Response and Chemotherapeutic Response.
Zhang J; Shih DJH; Lin SY
J Cancer Res Cell Ther; 2019; 3(1):. PubMed ID: 32577620
[TBL] [Abstract][Full Text] [Related]
42. MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes.
Ramírez J; Dege C; Kutateladze TG; Hagman J
Mol Cell Biol; 2012 Dec; 32(24):5078-88. PubMed ID: 23071088
[TBL] [Abstract][Full Text] [Related]
43. CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
[TBL] [Abstract][Full Text] [Related]
44. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
Cai Y; Geutjes EJ; de Lint K; Roepman P; Bruurs L; Yu LR; Wang W; van Blijswijk J; Mohammad H; de Rink I; Bernards R; Baylin SB
Oncogene; 2014 Apr; 33(17):2157-68. PubMed ID: 23708667
[TBL] [Abstract][Full Text] [Related]
45. Increased susceptibility of H-Ras(G12V)-transformed human urothelial cells to the genotoxic effects of sodium arsenite.
Liao YC; Chen YF; Lee TC
Arch Toxicol; 2015 Nov; 89(11):1971-9. PubMed ID: 25199681
[TBL] [Abstract][Full Text] [Related]
46. CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
McKenzie LD; LeClair JW; Miller KN; Strong AD; Chan HL; Oates EL; Ligon KL; Brennan CW; Chheda MG
Sci Rep; 2019 Mar; 9(1):4444. PubMed ID: 30872624
[TBL] [Abstract][Full Text] [Related]
47. Oxidative DNA damage and repair in children exposed to low levels of arsenic in utero and during early childhood: application of salivary and urinary biomarkers.
Hinhumpatch P; Navasumrit P; Chaisatra K; Promvijit J; Mahidol C; Ruchirawat M
Toxicol Appl Pharmacol; 2013 Dec; 273(3):569-79. PubMed ID: 24128852
[TBL] [Abstract][Full Text] [Related]
48. CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.
Hoffmeister H; Fuchs A; Erdel F; Pinz S; Gröbner-Ferreira R; Bruckmann A; Deutzmann R; Schwartz U; Maldonado R; Huber C; Dendorfer AS; Rippe K; Längst G
Nucleic Acids Res; 2017 Oct; 45(18):10534-10554. PubMed ID: 28977666
[TBL] [Abstract][Full Text] [Related]
49. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
50. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
51. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
52. RNAi screens identify CHD4 as an essential gene in breast cancer growth.
D'Alesio C; Punzi S; Cicalese A; Fornasari L; Furia L; Riva L; Carugo A; Curigliano G; Criscitiello C; Pruneri G; Pelicci PG; Faretta M; Bossi D; Lanfrancone L
Oncotarget; 2016 Dec; 7(49):80901-80915. PubMed ID: 27779108
[TBL] [Abstract][Full Text] [Related]
53. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
54. CHD3 and CHD4 recruitment and chromatin remodeling activity at DNA breaks is promoted by early poly(ADP-ribose)-dependent chromatin relaxation.
Smith R; Sellou H; Chapuis C; Huet S; Timinszky G
Nucleic Acids Res; 2018 Jul; 46(12):6087-6098. PubMed ID: 29733391
[TBL] [Abstract][Full Text] [Related]
55. Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Böhm M; Wachtel M; Marques JG; Streiff N; Laubscher D; Nanni P; Mamchaoui K; Santoro R; Schäfer BW
J Clin Invest; 2016 Nov; 126(11):4237-4249. PubMed ID: 27760049
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma.
Li J; Liang Y; Fan J; Xu C; Guan B; Zhang J; Guo B; Shi Y; Wang P; Tan Y; Zhang Q; Yuan C; Wu Y; Zhou L; Ci W; Li X
BMC Med; 2022 Jul; 20(1):222. PubMed ID: 35843958
[TBL] [Abstract][Full Text] [Related]
57. Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells.
Chai CY; Huang YC; Hung WC; Kang WY; Chen WT
Mutagenesis; 2007 Nov; 22(6):403-8. PubMed ID: 17906315
[TBL] [Abstract][Full Text] [Related]
58. Critical role of cellular glutathione homeostasis for trivalent inorganic arsenite-induced oxidative damage in human bronchial epithelial cells.
Jiang X; Chen C; Liu Y; Zhang P; Zhang Z
Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():35-45. PubMed ID: 25344162
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites.
Yager JW; Gentry PR; Thomas RS; Pluta L; Efremenko A; Black M; Arnold LL; McKim JM; Wilga P; Gill G; Choe KY; Clewell HJ
Environ Mol Mutagen; 2013 Mar; 54(2):82-98. PubMed ID: 23192986
[TBL] [Abstract][Full Text] [Related]
60. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
